跳至主要内容
临床试验/IRCT2016122631573N1
IRCT2016122631573N1已完成2 期

assessment of the effect of tranexamic acid on intraoperative blood loss in patients undergoing craniotomy for tumor excision

Ahvaz Jundishapur University Of Medical Sciences, Ahvaz, Iran0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Exclusion criteria: Patients with liver, kidney and blood disorders or with previous thrombosis disease; poses of bleeding disorders; abnormal coagulation parameters (prothrombin time and platelet count) ; systolic blood pressure more than 185 on the day of surgery; the patients who were taking aspirin or any kind of anticoagulant a week before the surgery; patients who had history of intracranial arteries surgery and also patients who their surgery will take 3 to 6 hours, will be excluded from study.
  • Brain Tumor; age range of 18 to 60 years; ASA class 1 or 2.

排除标准

  • 未提供

研究者

发起方
Ahvaz Jundishapur University Of Medical Sciences, Ahvaz, Iran

相似试验